{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:00:12Z","timestamp":1791237612155,"version":"4.1.0"},"reference-count":72,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:p>Prenatal testosterone (T) excess causes reproductive and metabolic disruptions including insulin resistance, attributes of women with polycystic ovary syndrome. This study tested the hypothesis that insulin resistance contributes toward severity of reproductive disruptions in prenatally T-treated females. Pregnant sheep were injected im with 100 mg of T-propionate semiweekly from d 30\u201390 of gestation. Immediately after the first breeding season, a subset of controls and prenatal T-treated (TR) sheep were administered an insulin sensitizer (rosiglitazone; 8 mg\/d) orally for 8 months. Untreated control and prenatal T-treated females (T group) were studied in parallel. Biochemical analyses revealed rosiglitazone to be safe for use in sheep. Glucose tolerance tests performed before and after the insulin sensitizer treatment found that insulin sensitizer decreased cumulative insulin, cumulative insulin\/glucose ratio, and insulin area under the curve by about 50% and increased the insulin sensitivity index by about 70% in the TR compared with the T group. Twenty percent of TR females showed a reduced number of cycles in the second relative to first breeding season as opposed to 80% of T group females showing such deterioration. Insulin sensitizer treatment also decreased the number of aberrant cycles (\u226518 d) during the second breeding season in the TR group relative to the first as opposed to the T group females showing an increase in the second breeding season relative to the first. These findings provide evidence that insulin sensitizer treatment prevents further deterioration of the reproductive axis in prenatal T-treated sheep, a finding of translational relevance to women with polycystic ovary syndrome.<\/jats:p>","DOI":"10.1210\/en.2010-0124","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T02:52:56Z","timestamp":1276743176000},"page":"4007-4017","source":"Crossref","is-referenced-by-count":26,"title":["Developmental Programming: Insulin Sensitizer Treatment Improves Reproductive Function in Prenatal Testosterone-Treated Female Sheep"],"prefix":"10.1210","volume":"151","author":[{"given":"Almudena","family":"Veiga-Lopez","sequence":"first","affiliation":[{"name":"Department of Pediatrics (A.V.-L., J.S.L., V.P.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pediatrics (A.V.-L., J.S.L., V.P.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Padmanabhan","sequence":"first","affiliation":[{"name":"Department of Pediatrics (A.V.-L., J.S.L., V.P.), University of Michigan, Ann Arbor, Michigan 48109"},{"name":"Department of the Reproductive Sciences Program (V.P.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"2020071612504431500_R1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/HUMREP\/11.3.465","article-title":"Polycystic ovary syndrome.","volume":"11","author":"Homburg","year":"1996","journal-title":"Hum Reprod"},{"key":"2020071612504431500_R2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0950-3552(97)80039-9","article-title":"Current concepts of polycystic ovary syndrome.","volume":"11","author":"Rosenfield","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"2020071612504431500_R3","first-page":"1299","article-title":"Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic \u03b2-cell.","volume":"13(Suppl 5)","author":"Ehrmann","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071612504431500_R4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2003.11.027","article-title":"Insulin resistance and metformin in polycystic ovary syndrome.","volume":"115","author":"Ben-Haroush","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071612504431500_R5","first-page":"315","article-title":"Pancreatic \u03b2-cells dysfunction in polycystic ovary syndrome.","volume":"50","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Panminerva Med"},{"key":"2020071612504431500_R6","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071612504431500_R7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humrep\/den433","article-title":"Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.","volume":"24","author":"Goverde","year":"2009","journal-title":"Hum Reprod"},{"key":"2020071612504431500_R8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","article-title":"Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.","volume":"63","author":"Berneis","year":"2009","journal-title":"Int J Clin Pract"},{"key":"2020071612504431500_R9","first-page":"295","article-title":"Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.","volume":"50","author":"Bethea","year":"2008","journal-title":"Panminerva Med"},{"key":"2020071612504431500_R10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome.","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2020071612504431500_R11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.psyneuen.2008.12.001","article-title":"Disturbed stress responses in women with polycystic ovary syndrome.","volume":"34","author":"Benson","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"2020071612504431500_R12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-992928","article-title":"Dietary therapy in polycystic ovary syndrome.","volume":"26","author":"Moran","year":"2008","journal-title":"Semin Reprod Med"},{"key":"2020071612504431500_R13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003053.pub4","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.","author":"Tang","year":"2010","journal-title":"Cochrane Database Syst Rev CD003053"},{"key":"2020071612504431500_R14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.","volume":"196","author":"Legro","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2020071612504431500_R15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071612504431500_R16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071612504431500_R17","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/humrep\/14.11.2700","article-title":"High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome.","volume":"14","author":"Mitwally","year":"1999","journal-title":"Hum Reprod"},{"key":"2020071612504431500_R18","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome.","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612504431500_R19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.reprotox.2006.12.009","article-title":"Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys.","volume":"23","author":"Zhou","year":"2007","journal-title":"Reprod Toxicol"},{"key":"2020071612504431500_R20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03350781","article-title":"Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.","volume":"21","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071612504431500_R21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1043-2760(98)00020-4","article-title":"Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction.","volume":"9","author":"Apter","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612504431500_R22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.","volume":"25","author":"Blank","year":"2007","journal-title":"Semin Reprod Med"},{"key":"2020071612504431500_R23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Identifying children at risk for polycystic ovary syndrome.","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612504431500_R24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612504431500_R25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ijo.2008.61","article-title":"Polycystic ovary syndrome in adolescents.","volume":"32","author":"Franks","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2020071612504431500_R26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins.","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"2020071612504431500_R27","first-page":"87","author":"Abbott","year":"2008"},{"key":"2020071612504431500_R28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mce.2005.11.016","article-title":"Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female.","volume":"246","author":"Padmanabhan","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612504431500_R29","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/en.2002-220965","article-title":"Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep.","volume":"144","author":"Birch","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612504431500_R30","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1210\/en.2007-0339","article-title":"Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone.","volume":"148","author":"Steckler","year":"2007","journal-title":"Endocrinology"},{"key":"2020071612504431500_R31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1095\/biolreprod.107.065904","article-title":"Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep.","volume":"78","author":"Veiga-Lopez","year":"2008","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R32","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1210\/en.2005-1338","article-title":"Fetal programming: prenatal testosterone treatment leads to follicular persistence\/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment.","volume":"147","author":"Manikkam","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612504431500_R33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.0.0730385","article-title":"Ovulation in prenatally androgenized ewes.","volume":"73","author":"Clarke","year":"1977","journal-title":"J Endocrinol"},{"key":"2020071612504431500_R34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1095\/biolreprod.104.035691","article-title":"Prenatal programming of reproductive neuroendocrine function: the effect of prenatal androgens on the development of estrogen positive feedback and ovarian cycles in the ewe.","volume":"72","author":"Unsworth","year":"2005","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R35","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1210\/en.2005-0322","article-title":"Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female.","volume":"146","author":"Sarma","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612504431500_R36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1095\/biolreprod66.4.924","article-title":"Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep.","volume":"66","author":"Sharma","year":"2002","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1095\/biolreprod.108.074781","article-title":"Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep.","volume":"80","author":"Veiga-Lopez","year":"2009","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R38","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1210\/endo.140.12.7205","article-title":"In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone.","volume":"140","author":"Robinson","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612504431500_R39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1530\/ror.0.0030130","article-title":"Sexual differentiation of reproductive neuroendocrine function in sheep.","volume":"3","author":"Wood","year":"1998","journal-title":"Rev Reprod"},{"key":"2020071612504431500_R40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0303-7207(01)00632-3","article-title":"Intra-follicular activin availability is altered in prenatally-androgenized lambs.","volume":"185","author":"West","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612504431500_R41","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1210\/en.2004-1444","article-title":"Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment.","volume":"146","author":"Steckler","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612504431500_R42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1095\/biolreprod.108.072801","article-title":"Developmental Programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep.","volume":"80","author":"Smith","year":"2009","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R43","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1152\/ajpendo.00107.2005","article-title":"Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone","volume":"289","author":"Recabarren","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612504431500_R44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/en.2009-1015","article-title":"Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.","volume":"151","author":"Padmanabhan","year":"2010","journal-title":"Endocrinology"},{"key":"2020071612504431500_R45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/en.2003-0478","article-title":"Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep.","volume":"145","author":"Manikkam","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612504431500_R46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2020071612504431500_R47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590500231627","article-title":"The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.","volume":"21","author":"Yilmaz","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"2020071612504431500_R48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00404-009-1305-8","article-title":"A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate.","volume":"281","author":"Roy","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"2020071612504431500_R49","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1089\/jwh.2008.0812","article-title":"Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.","volume":"17","author":"Shokeir","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"2020071612504431500_R50","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1E072","article-title":"Second-generation thiazolidinediones and hepatotoxicity.","volume":"38","author":"Marcy","year":"2004","journal-title":"Ann Pharmacother"},{"key":"2020071612504431500_R51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pds.1804","article-title":"Case series of liver failure associated with rosiglitazone and pioglitazone.","volume":"18","author":"Floyd","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020071612504431500_R52","first-page":"82","article-title":"Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.","volume":"165","author":"McMorran","year":"2001","journal-title":"CMAJ"},{"key":"2020071612504431500_R53","first-page":"Mosby","article-title":"Large animal internal medicine","volume":"Philadelphia","author":"Smith","year":"2002","journal-title":"3rd ed."},{"key":"2020071612504431500_R54","author":"Aitken","year":"2007"},{"key":"2020071612504431500_R55","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000127011","article-title":"Evidence for short or ultrashort loop negative feedback of gonadotropin-releasing hormone secretion.","volume":"62","author":"Padmanabhan","year":"1995","journal-title":"Neuroendocrinology"},{"key":"2020071612504431500_R56","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2020071612504431500_R57","first-page":"254","article-title":"Programming of GnRH feedback controls timing puberty and adult reproductive activity.","author":"Foster","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612504431500_R58","first-page":"Springer","article-title":"Permutation tests: a practical guide to resampling methods for testing hypotheses","volume":"York","author":"Phillip","year":"2000","journal-title":"2nd ed. New"},{"key":"2020071612504431500_R59","author":"Kaneko","year":"1997"},{"key":"2020071612504431500_R60","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1210\/en.2008-1256","article-title":"Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity: implication for polycystic ovary syndrome.","volume":"150","author":"Steckler","year":"2009","journal-title":"Endocrinology"},{"key":"2020071612504431500_R61","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome.","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev CD003053"},{"key":"2020071612504431500_R62","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome.","volume":"24","author":"De Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071612504431500_R63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diacare.25.5.815","article-title":"Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.","volume":"25","author":"Lebovitz","year":"2002","journal-title":"Diabetes Care"},{"key":"2020071612504431500_R64","first-page":"143","article-title":"The potential role of the transcription factor RZR\/ROR as a mediator of nuclear melatonin signaling.","volume":"12","author":"Wiesenberg","year":"1998","journal-title":"Restor Neurol Neurosci"},{"key":"2020071612504431500_R65","first-page":"19","article-title":"Melatonin in humans.","volume":"57(Suppl 5)","author":"Karasek","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"2020071612504431500_R66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1095\/biolreprod27.3.580","article-title":"Alterations in the control of luteinizing hormone pulse frequency underlie the seasonal variation in estradiol negative feedback in the ewe.","volume":"27","author":"Goodman","year":"1982","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin.","volume":"8","author":"Poretsky","year":"1987","journal-title":"Endocr Rev"},{"key":"2020071612504431500_R68","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells.","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"2020071612504431500_R69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1095\/biolreprod.107.063347","article-title":"Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep.","volume":"78","author":"Manikkam","year":"2008","journal-title":"Biol Reprod"},{"key":"2020071612504431500_R70","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.","volume":"81","author":"Willis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612504431500_R71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1477-7827-7-147","article-title":"Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.","volume":"7","author":"Chen","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"2020071612504431500_R72","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.","volume":"103","author":"Sam","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/8\/4007\/9015410\/endo4007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/8\/4007\/9015410\/endo4007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:06:10Z","timestamp":1594937170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/8\/4007\/2456970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2010-0124","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}